Ovid Therapeutics (OVID) Return on Equity [ROE] (2017 - 2026)
Ovid Therapeutics (OVID) recorded Return on Equity [ROE] of -16.90% in Q2 2026, up 49.46 percentage points from -66.36% a year earlier but down 2.21 percentage points from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Return on Equity [ROE] (2017 - 2026) Analysis & Trends
For FY2025, Ovid Therapeutics reported Return on Equity [ROE] of -17.51%, up 16.37 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of +125.09 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -33.88% in FY2024 (+13.68 pp), -47.57% in FY2023 (-12.84 pp), -34.72% in FY2022 (-144.70 pp) and 109.98% in FY2021 (+252.58 pp).
- Quarterly Return on Equity [ROE] has ranged from -72.31% in Q3 2025 to 65.20% in Q4 2021 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of +9.25 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 224.88 percentage points in Q3 2021, against a drop of 127.07 percentage points in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -14.69% (Q1 2026), -19.86% (Q4 2025) and -72.31% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Ovid Therapeutics | 460.04 Mn | 92.06 Mn | - | -16.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.90% |
| Mar 31, 2026 | -14.69% |
| Dec 31, 2025 | -19.86% |
| Sep 30, 2025 | -72.31% |
| Jun 30, 2025 | -66.36% |
| Mar 31, 2025 | -39.17% |
| Dec 31, 2024 | -36.58% |
| Sep 30, 2024 | -39.35% |
| Jun 30, 2024 | -35.59% |
| Mar 31, 2024 | -61.03% |
| Dec 31, 2023 | -55.36% |
| Sep 30, 2023 | -45.78% |
| Jun 30, 2023 | -42.51% |
| Mar 31, 2023 | -40.61% |
| Dec 31, 2022 | -39.49% |
| Sep 30, 2022 | -46.68% |
| Jun 30, 2022 | -42.93% |
| Mar 31, 2022 | -40.19% |
| Dec 31, 2021 | 65.20% |
| Sep 30, 2021 | 62.82% |
API Access
Ovid Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();